These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 28532690)

  • 1. Combinatorial drug delivery approaches for immunomodulation.
    Stewart JM; Keselowsky BG
    Adv Drug Deliv Rev; 2017 May; 114():161-174. PubMed ID: 28532690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor immune microenvironment modulation-based drug delivery strategies for cancer immunotherapy.
    Han S; Huang K; Gu Z; Wu J
    Nanoscale; 2020 Jan; 12(2):413-436. PubMed ID: 31829394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adapting conventional cancer treatment for immunotherapy.
    Qiao J; Liu Z; Fu YX
    J Mol Med (Berl); 2016 May; 94(5):489-95. PubMed ID: 26910191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering vaccines and niches for immune modulation.
    Purwada A; Roy K; Singh A
    Acta Biomater; 2014 Apr; 10(4):1728-40. PubMed ID: 24373907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering tolerance using biomaterials to target and control antigen presenting cells.
    Tostanoski LH; Gosselin EA; Jewell CM
    Discov Med; 2016 May; 21(117):403-10. PubMed ID: 27355336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancing immunotherapy using biomaterials to control tissue, cellular, and molecular level immune signaling in skin.
    Shah SA; Oakes RS; Jewell CM
    Adv Drug Deliv Rev; 2024 Jun; 209():115315. PubMed ID: 38670230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery strategies of cancer immunotherapy: recent advances and future perspectives.
    Zhao Z; Zheng L; Chen W; Weng W; Song J; Ji J
    J Hematol Oncol; 2019 Nov; 12(1):126. PubMed ID: 31779642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supramolecular biomaterials for enhanced cancer immunotherapy.
    Zhang H; Zhu J; Fang T; Li M; Chen G; Chen Q
    J Mater Chem B; 2022 Sep; 10(37):7183-7193. PubMed ID: 35348177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced Biomaterials with Intrinsic Immunomodulation Effects for Cancer Immunotherapy.
    Chen W; Li C; Jiang X
    Small Methods; 2023 May; 7(5):e2201404. PubMed ID: 36811240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoengineering the next generation of arthritis therapies.
    Klimak M; Nims RJ; Pferdehirt L; Collins KH; Harasymowicz NS; Oswald SJ; Setton LA; Guilak F
    Acta Biomater; 2021 Oct; 133():74-86. PubMed ID: 33823324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoengineering with biomaterials for enhanced cancer immunotherapy.
    Xie YQ; Wei L; Tang L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Jul; 10(4):e1506. PubMed ID: 29333729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgery-free injectable macroscale biomaterials for local cancer immunotherapy.
    Lei K; Tang L
    Biomater Sci; 2019 Feb; 7(3):733-749. PubMed ID: 30637428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomaterials for direct and indirect immunomodulation: A review of applications.
    Kubackova J; Zbytovska J; Holas O
    Eur J Pharm Sci; 2020 Jan; 142():105139. PubMed ID: 31704342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy in ovarian cancer.
    Krishnan V; Berek JS; Dorigo O
    Curr Probl Cancer; 2017; 41(1):48-63. PubMed ID: 28169004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal immunomodulation: Principles, advances and perspectives.
    Zhao Z; Ukidve A; Dasgupta A; Mitragotri S
    Adv Drug Deliv Rev; 2018 Mar; 127():3-19. PubMed ID: 29604373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic Acid and Its Derivatives in Coating and Delivery Systems: Applications in Tissue Engineering, Regenerative Medicine and Immunomodulation.
    Knopf-Marques H; Pravda M; Wolfova L; Velebny V; Schaaf P; Vrana NE; Lavalle P
    Adv Healthc Mater; 2016 Nov; 5(22):2841-2855. PubMed ID: 27709832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of polymeric nanoparticles in immunotherapy.
    Craparo EF; Bondì ML
    Curr Opin Allergy Clin Immunol; 2012 Dec; 12(6):658-64. PubMed ID: 23095912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphatic immunomodulation using engineered drug delivery systems for cancer immunotherapy.
    Manspeaker MP; Thomas SN
    Adv Drug Deliv Rev; 2020; 160():19-35. PubMed ID: 33058931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local biomaterials-assisted cancer immunotherapy to trigger systemic antitumor responses.
    Chen Q; Chen M; Liu Z
    Chem Soc Rev; 2019 Nov; 48(22):5506-5526. PubMed ID: 31589233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and Development of Immunomodulatory Antigen Delivery Systems Based on Peptide/PEG-PLA Conjugate for Tuning Immunity.
    Coumes F; Huang CY; Huang CH; Coudane J; Domurado D; Li S; Darcos V; Huang MH
    Biomacromolecules; 2015 Nov; 16(11):3666-73. PubMed ID: 26473322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.